Real-time enrollment status for this atrial fibrillation clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 9:05 PM UTC
| NCT Number | NCT04045665 |
| Recruiting Status | Recruiting |
| Condition | Atrial Fibrillation |
| Phase | PHASE3 |
| Target Enrollment | 3,200 participants |
| Active Locations | 51 sites in the US |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Last Updated on CT.gov | June 26, 2026 (Jun 26, 2026) |
As of October 15, 2026: Clinical trial NCT04045665 is currently recruiting participants. This phase3 study for atrial fibrillation is actively seeking new participants at 51 locations across the United States. The study is sponsored by Icahn School of Medicine at Mount Sinai. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04045665 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 51 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04045665 was last updated Jun 26, 2026 (June 26, 2026). HelloStudys verifies this status automatically.